The MarketWatch News Department was not involved in the creation of this content. bioAffinity Technologies' noninvasive diagnostic shifted the course of care from watchful waiting for up to 5 years to ...
In a 2024 Journal of Thoracic Oncology review, Haiquan Chen, MD, PhD, of Fudan University Shanghai Cancer Center in China, and colleagues backed the use of selective lymph node dissection (LND) to ...
Northwestern Medicine Central DuPage Hospital in Winfield is integrating three cutting-edge technologies - the daVinci robot, the Monarch robot, and Firefly fluorescence imaging - all in one operating ...
Introduction: Hook-wire (HW) localization is the most frequently employed approach for preoperative localization of pulmonary ground-glass nodules (GGNs); however, the relative outcomes of ...
bioAffinity Technologies’ noninvasive diagnostic shifted the course of care from watchful waiting for up to 5 years to confirmed malignancy and immediate treatment SAN ANTONIO, September 09, ...
bioAffinity Technologies’ noninvasive diagnostic shifted the course of care from watchful waiting for up to 5 years to confirmed malignancy and immediate treatment Ground-glass nodules appear in ...
bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today released another compelling case study in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback